1. Home
  2. PLUR vs TACT Comparison

PLUR vs TACT Comparison

Compare PLUR & TACT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Pluri Inc.

PLUR

Pluri Inc.

N/A

Current Price

$3.31

Market Cap

33.9M

Sector

Health Care

ML Signal

N/A

Logo TransAct Technologies Incorporated

TACT

TransAct Technologies Incorporated

HOLD

Current Price

$3.42

Market Cap

37.2M

Sector

Technology

ML Signal

HOLD

Company Overview

Basic Information
Metric
PLUR
TACT
Founded
2001
1996
Country
Israel
United States
Employees
N/A
N/A
Industry
Biotechnology: Biological Products (No Diagnostic Substances)
Computer peripheral equipment
Sector
Health Care
Technology
Exchange
Nasdaq
Nasdaq
Market Cap
33.9M
37.2M
IPO Year
2001
1996

Fundamental Metrics

Financial Performance
Metric
PLUR
TACT
Price
$3.31
$3.42
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
1
1
Target Price
$12.00
$5.00
AVG Volume (30 Days)
6.3K
41.5K
Earning Date
01-01-0001
06-15-2026
Dividend Yield
N/A
N/A
EPS Growth
10.78
87.88
EPS
N/A
N/A
Revenue
$1,336,000.00
N/A
Revenue This Year
$97.38
$21.67
Revenue Next Year
$293.97
$7.63
P/E Ratio
N/A
N/A
Revenue Growth
309.82
N/A
52 Week Low
$2.82
$3.06
52 Week High
$7.13
$5.70

Technical Indicators

Market Signals
Indicator
PLUR
TACT
Relative Strength Index (RSI) 51.27 44.89
Support Level $3.13 N/A
Resistance Level $3.91 $3.87
Average True Range (ATR) 0.16 0.22
MACD -0.03 -0.00
Stochastic Oscillator 44.07 50.72

Price Performance

Historical Comparison
PLUR
TACT

About PLUR Pluri Inc.

Pluri Inc is a biotechnology company engaged in the research, development, and manufacturing of cell-based products, as well as the commercialization of cell therapeutics and related technologies aimed at delivering solutions across a range of industries, including regenerative medicine, immunotherapy, food tech, CDMO, and AgTech. The company uses its 3D cell expansion technology platform to develop placenta-based cell therapy product candidates (PLX-PAD and PLX-R18) for the treatment of inflammatory, muscle injuries, and hematologic conditions. In addition, it offers CDMO services through PluriCDMO, has launched a novel immunotherapy platform, and is engaged in developing cultivated, cell-cultured coffee and meat.

About TACT TransAct Technologies Incorporated

Transact Technologies Inc develops and sells software-driven technology and printing solutions. The company's software is sold under BOHA, AccuDate, Epic, EPICENTRAL, Ithaca, and Printrex brand names. It also provides supplies and consumables used in the printing and scanning activities to restaurant and hospitality, banking, retail, casino and gaming, point of sale automation, lottery, medical, mobile, oil, and gas markets. Majority of the revenue is derived from the casinos and gaming industry followed by the Foodservice technology market. Its geographical segments are the United States and International, of which the majority of its revenue comes from the United States.

Share on Social Networks: